Valicenti Advisory Services Inc. Sells 2,435 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Valicenti Advisory Services Inc. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,844 shares of the medical equipment provider's stock after selling 2,435 shares during the quarter. Intuitive Surgical comprises 3.5% of Valicenti Advisory Services Inc.'s portfolio, making the stock its 6th biggest position. Valicenti Advisory Services Inc.'s holdings in Intuitive Surgical were worth $13,790,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ISRG. Golden State Equity Partners increased its position in shares of Intuitive Surgical by 14.6% in the first quarter. Golden State Equity Partners now owns 1,209 shares of the medical equipment provider's stock worth $599,000 after acquiring an additional 154 shares in the last quarter. Lecap Asset Management Ltd. acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $1,779,000. Balance Wealth LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at $1,223,000. TABR Capital Management LLC purchased a new position in shares of Intuitive Surgical in the first quarter valued at $209,000. Finally, International Assets Investment Management LLC grew its holdings in Intuitive Surgical by 14.5% during the 1st quarter. International Assets Investment Management LLC now owns 2,379 shares of the medical equipment provider's stock valued at $1,178,000 after purchasing an additional 301 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 215 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $549.06, for a total transaction of $118,047.90. Following the transaction, the senior vice president now owns 1,768 shares of the company's stock, valued at approximately $970,738.08. This trade represents a 10.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Evercore ISI reduced their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $588.95.

Intuitive Surgical Trading Up 2.4%

ISRG traded up $12.56 during trading hours on Thursday, hitting $534.19. The company's stock had a trading volume of 1,965,145 shares, compared to its average volume of 1,672,340. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The company has a 50-day simple moving average of $530.03 and a 200 day simple moving average of $536.86. The firm has a market capitalization of $191.46 billion, a PE ratio of 78.33, a PEG ratio of 5.55 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.